Welcome to our dedicated page for CORVEL SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CorVel Corporation's SEC filings document the company's public-company reporting for a technology-enabled risk management business serving workers' compensation and health, auto, and liability programs. Recent 8-K filings furnish quarterly financial results through Item 2.02 disclosures and related earnings press releases.
CorVel's proxy and annual meeting filings cover stockholder voting matters, director elections, auditor ratification, and governance procedures. The filings also identify the company's common stock, par value $0.0001 per share, traded under CRVL on the Nasdaq Global Select Market, tying its governance record to its listed equity security.
CorVel Corp (CRVL) reported that major shareholder Corstar Holdings Inc, a ten percent owner, sold a total of 66,251 shares of CorVel common stock in open market or private transactions under a Rule 10b5-1 trading plan. The sales occurred on September 3, 2026 (51,713 shares at $68.9112 per share) and September 4, 2026 (14,538 shares at $68.7559 per share).
CORVEL CORP (CRVL) has a notice of proposed sale under Rule 144 filed on behalf of Corstar Holdings Inc., identified as a 10% stockholder and affiliate. Corstar plans to sell 14,538 shares of CorVel common stock through UBS Financial Services Inc. in a transaction listed on NASDAQ.
The filing states an aggregate market value for the planned sale of $996,289.14 and reports that CorVel had 50,516,571 shares outstanding as of September 4, 2026; this is a baseline figure, not the amount being offered. During the prior three months, sales included 9,000 shares by Jeffrey Michael and 51,713 shares by Corstar Holdings Inc.
CORVEL CORP (CRVL) has a planned secondary sale under Rule 144 by affiliate and 10% stockholder Corstar Holdings Inc. Corstar has filed to sell up to 51,713 shares of common stock through UBS Financial Services Inc., with an aggregate market value of $50,516,571 as of the notice. CorVel reports 3,561,753.56 shares outstanding of the same class. The shares to be sold were acquired as founders shares from the issuer on May 1, 1991.
CORVEL CORP (CRVL) director R. Judd Jessup reported selling common shares. On September 1, 2026, he sold 4,023 shares of CorVel common stock at a reported price of $70.07 per share in an open-market or private transaction. After this sale, he directly held 111,798 shares of CorVel common stock, and no Rule 10b5-1 trading plan is reported.
CORVEL CORP (CRVL) director R. Judd Jessup reported two open-market sales of common stock. On August 26, 2026, he sold 1,562 shares at $70.71 per share, and on August 27, 2026 he sold 1,262 shares at $70.64 per share, for a total of 2,824 shares sold. The reported entries reflect directly held, non-derivative common stock; post-transaction holdings are not provided in this filing.
CORVEL CORP (CRVL) has a beneficial holder, Robert Judd Jessup, filing a Rule 144 notice for a proposed sale of common stock. The notice lists 6,847 shares of CorVel common stock to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of 486,479.00. The shares relate to a stock option exercise on 06/11/2026, paid by cash/check. CorVel common stock shares outstanding are stated as 50,516,571, and the securities are listed on NASDAQ. The form is signed on Jessup’s behalf by a duly authorized representative of Fidelity as attorney-in-fact.
CORVEL CORP (CRVL) reported that Vice President of Accounting Jennifer Yoss exercised a non-qualified stock option for 2,100 shares of common stock at an exercise price of $65.72 per share and on the same date sold 2,100 shares at $70.915 per share. Following the option exercise, 852 option shares remain, with the option expiring on December 8, 2026. The option vests based on achievement of certain earnings-growth performance criteria.
CorVel Corporation (CRVL) is the issuer for a planned sale of its common stock by officer Jennifer Yoss under Rule 144. The notice covers 2,100 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, following a stock option exercise on 08/20/2026, for cash.
The filing also reports that Yoss sold 1,999 shares of CorVel common stock on 05/26/2026 during the prior three months.
CorVel Corporation held its 2026 annual meeting of stockholders on August 6, 2026, where three proposals were voted on. There were 51,009,059 shares of common stock outstanding at the close of business on June 8, 2026, the record date for the meeting.
Stockholders elected six directors to serve until the 2027 annual meeting, with each nominee receiving more votes "For" than "Withheld"; for example, Michael G. Combs received 43,814,558 votes For and 3,455,744 Withheld, and Joanna C. Burkey received 44,498,930 For and 2,771,372 Withheld. Stockholders also ratified the appointment of Haskell & White LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 48,565,751 votes For, 414,690 Against, and 18,593 Abstain. In a non-binding advisory vote, stockholders approved the compensation of the named executive officers, with 42,909,830 votes For, 1,551,017 Against, 2,809,455 Abstain, and 1,728,732 broker non-votes.
CorVel Corp reported that director and ten percent owner Jeffrey J. Michael received a grant of 1,500 Non-Qualified Stock Options on 2026-08-06. The options carry an exercise price of $62.45 per share and expire on 2036-08-06. According to the vesting terms, they become exercisable in four equal annual installments beginning 12 months after the grant date, and this grant brings his reported derivative holdings from this award to 1,500 options.